PI Industries shares slip as Q1 2026 growth disappoints
Agrochemical firm posts muted quarterly results, with stock declining after earnings call highlights weaker-than-expected revenue and profit margins.

Shares of PI Industries fell on Tuesday after the company reported muted growth in its first quarter of fiscal 2026, as revenue and profit margins missed analyst expectations.
The agrochemical producer, which serves both domestic and international markets, disclosed a 5% year-over-year decline in consolidated revenue to ₹1.25 billion ($15.1 million) for the quarter ended June 30. Net profit contracted 8% to ₹180 million ($2.2 million), reflecting pressure on margins amid higher input costs and competitive pricing in key segments.
During an earnings call, PI Industries’ management cited slower demand in the crop protection segment, particularly in Europe and parts of Asia, as a primary headwind. While domestic sales in India remained resilient, growth was insufficient to offset declines in export markets. The company also noted elevated raw material prices, including for key active ingredients, which squeezed profitability despite cost optimization efforts.
Analysts had anticipated revenue of ₹1.32 billion and net profit of ₹200 million for the quarter, according to a Reuters poll of estimates. The underperformance triggered a 3.2% drop in PI Industries’ stock on the National Stock Exchange of India, extending losses from the prior session.
Looking ahead, PI Industries reaffirmed its full-year guidance, projecting revenue growth of 8-10% and margin expansion as supply chain conditions stabilize. However, management warned that geopolitical tensions and currency volatility could pose risks to its outlook. The company plans to focus on product innovation and geographic diversification to mitigate near-term challenges.
Investors will closely monitor the next quarterly update for signs of stabilization in demand and margin recovery.


Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.
More from Priya Anand →